RELATED CONTENT
NEWS
- Express Scripts $29.1 billion bid for Medco will hit US FTC scrutiny and squeeze pharma
- Biogen/Elan hope updated Tysabri label will lend confidence to patients/prescribers
- Stockwatch: The perils of a successful biotech
- European generics firms, squeezed between innovators and payers, seek diversity
FEATURES
Other Informa Features


